Prostate laser vaporization is safe and effective in elderly men

Introduction: There are few data on the safety and efficacy of laser photoselective vaporization (LVP) in elderly men. We compared the safety and efficacy of LVP for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men ≥75 years, who we defined as elderly, to those <75 years. M...

Full description

Bibliographic Details
Main Authors: Rohit Majumdar, Hossein S Mirheydar, Kerrin L Palazzi, Charles M Lakin, Michael E Albo, J Kellogg Parsons
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Urology Annals
Subjects:
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2015;volume=7;issue=1;spage=36;epage=40;aulast=Majumdar
id doaj-8537d483bbd6479184269884410607e5
record_format Article
spelling doaj-8537d483bbd6479184269884410607e52020-11-24T22:16:38ZengWolters Kluwer Medknow PublicationsUrology Annals0974-77960974-78342015-01-0171364010.4103/0974-7796.148595Prostate laser vaporization is safe and effective in elderly menRohit MajumdarHossein S MirheydarKerrin L PalazziCharles M LakinMichael E AlboJ Kellogg ParsonsIntroduction: There are few data on the safety and efficacy of laser photoselective vaporization (LVP) in elderly men. We compared the safety and efficacy of LVP for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men ≥75 years, who we defined as elderly, to those <75 years. Materials and Methods: Safety and efficacy outcomes in elderly men undergoing LVP for lower urinary tract symptoms secondary to BPH from 2005 to 2012 were compared with men <75 years. Differences between-groups in demographics, perioperative outcomes, complications, and postoperative changes in International Prostate Symptom Score (I-PSS) were calculated. Results: Of 202 patients, 49 (24%) were elderly (range: 75-95 years) and 153 (76%) were <75 years. Preoperatively, elderly men were more likely to have heart disease (35% vs. 20%, P = 0.03), gross hematuria (6.1% vs. 0.7%, P = 0.05), urinary retention (57% vs. 41%, P = 0.07), and take anti-coagulants (61% vs. 35%, P = 0.002). Elderly men had a longer median length of stay (1 day vs. 0 day, P = 0.001). There were no significant between-group differences in transfusion frequency (4.4% vs. 0.7%, P = 0.14) or Clavien III complications (2% vs. 2.6%, P = 1.0). One month postsurgery, elderly patients reported smaller median decreases in I-PSS (5.5 vs. 9, P = 0.02) and urinary bother (1 point vs. 2, P = 0.03) compared with preoperative values. At till 9 months follow-up, there were no significant between-group differences in median I-PSS or urinary bother scores. Conclusions: Despite a higher prevalence of preoperative comorbidity and urinary retention, elderly LVP patients experienced perioperative safety and shorter term efficacy outcomes comparable to younger men.http://www.urologyannals.com/article.asp?issn=0974-7796;year=2015;volume=7;issue=1;spage=36;epage=40;aulast=MajumdarBenign prostatic hyperplasiacomplicationselderlylower urinary tract symptomsoutcomes
collection DOAJ
language English
format Article
sources DOAJ
author Rohit Majumdar
Hossein S Mirheydar
Kerrin L Palazzi
Charles M Lakin
Michael E Albo
J Kellogg Parsons
spellingShingle Rohit Majumdar
Hossein S Mirheydar
Kerrin L Palazzi
Charles M Lakin
Michael E Albo
J Kellogg Parsons
Prostate laser vaporization is safe and effective in elderly men
Urology Annals
Benign prostatic hyperplasia
complications
elderly
lower urinary tract symptoms
outcomes
author_facet Rohit Majumdar
Hossein S Mirheydar
Kerrin L Palazzi
Charles M Lakin
Michael E Albo
J Kellogg Parsons
author_sort Rohit Majumdar
title Prostate laser vaporization is safe and effective in elderly men
title_short Prostate laser vaporization is safe and effective in elderly men
title_full Prostate laser vaporization is safe and effective in elderly men
title_fullStr Prostate laser vaporization is safe and effective in elderly men
title_full_unstemmed Prostate laser vaporization is safe and effective in elderly men
title_sort prostate laser vaporization is safe and effective in elderly men
publisher Wolters Kluwer Medknow Publications
series Urology Annals
issn 0974-7796
0974-7834
publishDate 2015-01-01
description Introduction: There are few data on the safety and efficacy of laser photoselective vaporization (LVP) in elderly men. We compared the safety and efficacy of LVP for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men ≥75 years, who we defined as elderly, to those <75 years. Materials and Methods: Safety and efficacy outcomes in elderly men undergoing LVP for lower urinary tract symptoms secondary to BPH from 2005 to 2012 were compared with men <75 years. Differences between-groups in demographics, perioperative outcomes, complications, and postoperative changes in International Prostate Symptom Score (I-PSS) were calculated. Results: Of 202 patients, 49 (24%) were elderly (range: 75-95 years) and 153 (76%) were <75 years. Preoperatively, elderly men were more likely to have heart disease (35% vs. 20%, P = 0.03), gross hematuria (6.1% vs. 0.7%, P = 0.05), urinary retention (57% vs. 41%, P = 0.07), and take anti-coagulants (61% vs. 35%, P = 0.002). Elderly men had a longer median length of stay (1 day vs. 0 day, P = 0.001). There were no significant between-group differences in transfusion frequency (4.4% vs. 0.7%, P = 0.14) or Clavien III complications (2% vs. 2.6%, P = 1.0). One month postsurgery, elderly patients reported smaller median decreases in I-PSS (5.5 vs. 9, P = 0.02) and urinary bother (1 point vs. 2, P = 0.03) compared with preoperative values. At till 9 months follow-up, there were no significant between-group differences in median I-PSS or urinary bother scores. Conclusions: Despite a higher prevalence of preoperative comorbidity and urinary retention, elderly LVP patients experienced perioperative safety and shorter term efficacy outcomes comparable to younger men.
topic Benign prostatic hyperplasia
complications
elderly
lower urinary tract symptoms
outcomes
url http://www.urologyannals.com/article.asp?issn=0974-7796;year=2015;volume=7;issue=1;spage=36;epage=40;aulast=Majumdar
work_keys_str_mv AT rohitmajumdar prostatelaservaporizationissafeandeffectiveinelderlymen
AT hosseinsmirheydar prostatelaservaporizationissafeandeffectiveinelderlymen
AT kerrinlpalazzi prostatelaservaporizationissafeandeffectiveinelderlymen
AT charlesmlakin prostatelaservaporizationissafeandeffectiveinelderlymen
AT michaelealbo prostatelaservaporizationissafeandeffectiveinelderlymen
AT jkelloggparsons prostatelaservaporizationissafeandeffectiveinelderlymen
_version_ 1725788639017828352